BioSpace News Archive

9 Meters Biopharma, Inc. today provided an overview of its recent achievements, important upcoming milestones, and financial results for the second quarter ended June 30, 2022.

Moderna, Inc today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted conditional authorization for the use of the Omicron-containing bivalent COVID-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron▼) as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH), today announced the sale of $67.5 million in aggregate principal amount of a new series of variable rate convertible senior secured notes due December 15, 2025 (the “2025 Notes”) in a private placement transaction, raising approximately $22.5 million in gross cash proceeds after paying for a repurchase of $45.0 million of its 6.25% convertible senior notes due 2026.

Ainos, Inc. today announced its unaudited financial results for the second quarter ended June 30, 2022.

Inozyme Pharma, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided recent business highlights.

Vivos Therapeutics, Inc. today announced that it will reschedule the release of its financial results for the second quarter ended June 30, 2022 and related conference call, both previously scheduled for Monday, August 15, 2022.

GreenLight Biosciences today reported operational highlights and financial results for the second quarter ended June 30, 2022.

atai Life Sciences N.V. today reported financial results for the quarter ended June 30, 2022, and provided a business update.

Miravo Healthcare ™ Announces Second Quarter 2022 Results.

Columbia Care Inc. today reported financial and operating results for the second quarter ended June 30, 2022.